Cargando…

OR21-4 Heart Health 4 Moms: A Randomized Trial to Reduce Cardiovascular Risk in Women with Recent Preeclampsia

BACKGROUND: Preeclampsia is associated with a 2 to 3-fold increased risk for future maternal cardiovascular disease (CVD).To reduce CVD risk and overcome participation barriers, we tested an online intervention to promote a healthy lifestyle among women with recent preeclampsia. METHODS: We conducte...

Descripción completa

Detalles Bibliográficos
Autores principales: Seely, Ellen, Stuart, Jennifer, Skurnik, Geraldine, Roche, Andrea, Tsigas, Eleni, Fitzmaurice, Garrett, Wilkins-Haug, Louise, Levkoff, Sue, Rich-Edwards, Janet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554792/
http://dx.doi.org/10.1210/js.2019-OR21-4
_version_ 1783425020032188416
author Seely, Ellen
Stuart, Jennifer
Skurnik, Geraldine
Roche, Andrea
Tsigas, Eleni
Fitzmaurice, Garrett
Wilkins-Haug, Louise
Levkoff, Sue
Rich-Edwards, Janet
author_facet Seely, Ellen
Stuart, Jennifer
Skurnik, Geraldine
Roche, Andrea
Tsigas, Eleni
Fitzmaurice, Garrett
Wilkins-Haug, Louise
Levkoff, Sue
Rich-Edwards, Janet
author_sort Seely, Ellen
collection PubMed
description BACKGROUND: Preeclampsia is associated with a 2 to 3-fold increased risk for future maternal cardiovascular disease (CVD).To reduce CVD risk and overcome participation barriers, we tested an online intervention to promote a healthy lifestyle among women with recent preeclampsia. METHODS: We conducted a 9-month randomized controlled trial among 151 US women with preeclampsia within the prior 5 years. Preeclampsia history was validated by medical record review for new-onset hypertension (systolic blood pressure ≥140 and/or diastolic blood pressure ≥90 mm Hg) with proteinuria (≥ 300 mg/24hr, or urine protein/urine creatinine ratio ≥ 0.3 or urine dipstick ≥ 1+) after 20 weeks gestation. The intervention group received a patient-centered program, Heart Health 4 Moms (HH4M), created with input from preeclampsia survivors and the Preeclampsia Foundation. The program, available in English and Spanish, included online educational modules, a community forum, heart healthy resources (e.g., meal plans), and communication with a lifestyle coach including 6 scheduled phone calls. The control group received access to a website with links to CVD risk reduction websites accessible to the general public. Primary outcomes were self-efficacy for healthy eating and increasing physical activity; change in physical activity/inactivity; adherence to the Dietary Approaches to Stop Hypertension diet; and knowledge of and personal control over CVD risk. Secondary outcomes were weight and blood pressure. We used the Hochberg method to adjust the p value for multiple comparisons. RESULTS: Participants were, on average, 31 years of age, 1.3 years removed from their preeclampsia pregnancy, predominantly non-Hispanic white and resided in 41 US states. Retention rates were high (control 93%; intervention 91%). During the 9 months of follow-up, 69% of control participants and 99% of intervention participants visited the study website (p<0.00001). In the intervention arm, 84% of participants accessed at least one online educational module and 89% completed at least three scheduled calls with the coach. At the end of follow-up, intervention participants reported increased self-efficacy for healthy eating (p=0.03), greater knowledge of CVD risk factors (p=0.01), and less physical inactivity (p=0.0006) than individuals in the control arm. The groups did not differ in personal control over CVD risk, self-efficacy for physical activity, or reported physical activity levels. There were no differences in secondary outcomes between groups. CONCLUSIONS: The on-line HH4M program was used by women with recent preeclampsia across the US, improved their self-efficacy to achieve a healthy diet and their knowledge of CVD risk and reduced their physical inactivity. HH4M provides a model for an on-line, easily-accessible lifestyle program to reduce CVD risk in women with recent preeclampsia. (Funded by PCORI).
format Online
Article
Text
id pubmed-6554792
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65547922019-06-13 OR21-4 Heart Health 4 Moms: A Randomized Trial to Reduce Cardiovascular Risk in Women with Recent Preeclampsia Seely, Ellen Stuart, Jennifer Skurnik, Geraldine Roche, Andrea Tsigas, Eleni Fitzmaurice, Garrett Wilkins-Haug, Louise Levkoff, Sue Rich-Edwards, Janet J Endocr Soc Cardiovascular Endocrinology BACKGROUND: Preeclampsia is associated with a 2 to 3-fold increased risk for future maternal cardiovascular disease (CVD).To reduce CVD risk and overcome participation barriers, we tested an online intervention to promote a healthy lifestyle among women with recent preeclampsia. METHODS: We conducted a 9-month randomized controlled trial among 151 US women with preeclampsia within the prior 5 years. Preeclampsia history was validated by medical record review for new-onset hypertension (systolic blood pressure ≥140 and/or diastolic blood pressure ≥90 mm Hg) with proteinuria (≥ 300 mg/24hr, or urine protein/urine creatinine ratio ≥ 0.3 or urine dipstick ≥ 1+) after 20 weeks gestation. The intervention group received a patient-centered program, Heart Health 4 Moms (HH4M), created with input from preeclampsia survivors and the Preeclampsia Foundation. The program, available in English and Spanish, included online educational modules, a community forum, heart healthy resources (e.g., meal plans), and communication with a lifestyle coach including 6 scheduled phone calls. The control group received access to a website with links to CVD risk reduction websites accessible to the general public. Primary outcomes were self-efficacy for healthy eating and increasing physical activity; change in physical activity/inactivity; adherence to the Dietary Approaches to Stop Hypertension diet; and knowledge of and personal control over CVD risk. Secondary outcomes were weight and blood pressure. We used the Hochberg method to adjust the p value for multiple comparisons. RESULTS: Participants were, on average, 31 years of age, 1.3 years removed from their preeclampsia pregnancy, predominantly non-Hispanic white and resided in 41 US states. Retention rates were high (control 93%; intervention 91%). During the 9 months of follow-up, 69% of control participants and 99% of intervention participants visited the study website (p<0.00001). In the intervention arm, 84% of participants accessed at least one online educational module and 89% completed at least three scheduled calls with the coach. At the end of follow-up, intervention participants reported increased self-efficacy for healthy eating (p=0.03), greater knowledge of CVD risk factors (p=0.01), and less physical inactivity (p=0.0006) than individuals in the control arm. The groups did not differ in personal control over CVD risk, self-efficacy for physical activity, or reported physical activity levels. There were no differences in secondary outcomes between groups. CONCLUSIONS: The on-line HH4M program was used by women with recent preeclampsia across the US, improved their self-efficacy to achieve a healthy diet and their knowledge of CVD risk and reduced their physical inactivity. HH4M provides a model for an on-line, easily-accessible lifestyle program to reduce CVD risk in women with recent preeclampsia. (Funded by PCORI). Endocrine Society 2019-04-30 /pmc/articles/PMC6554792/ http://dx.doi.org/10.1210/js.2019-OR21-4 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Cardiovascular Endocrinology
Seely, Ellen
Stuart, Jennifer
Skurnik, Geraldine
Roche, Andrea
Tsigas, Eleni
Fitzmaurice, Garrett
Wilkins-Haug, Louise
Levkoff, Sue
Rich-Edwards, Janet
OR21-4 Heart Health 4 Moms: A Randomized Trial to Reduce Cardiovascular Risk in Women with Recent Preeclampsia
title OR21-4 Heart Health 4 Moms: A Randomized Trial to Reduce Cardiovascular Risk in Women with Recent Preeclampsia
title_full OR21-4 Heart Health 4 Moms: A Randomized Trial to Reduce Cardiovascular Risk in Women with Recent Preeclampsia
title_fullStr OR21-4 Heart Health 4 Moms: A Randomized Trial to Reduce Cardiovascular Risk in Women with Recent Preeclampsia
title_full_unstemmed OR21-4 Heart Health 4 Moms: A Randomized Trial to Reduce Cardiovascular Risk in Women with Recent Preeclampsia
title_short OR21-4 Heart Health 4 Moms: A Randomized Trial to Reduce Cardiovascular Risk in Women with Recent Preeclampsia
title_sort or21-4 heart health 4 moms: a randomized trial to reduce cardiovascular risk in women with recent preeclampsia
topic Cardiovascular Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554792/
http://dx.doi.org/10.1210/js.2019-OR21-4
work_keys_str_mv AT seelyellen or214hearthealth4momsarandomizedtrialtoreducecardiovascularriskinwomenwithrecentpreeclampsia
AT stuartjennifer or214hearthealth4momsarandomizedtrialtoreducecardiovascularriskinwomenwithrecentpreeclampsia
AT skurnikgeraldine or214hearthealth4momsarandomizedtrialtoreducecardiovascularriskinwomenwithrecentpreeclampsia
AT rocheandrea or214hearthealth4momsarandomizedtrialtoreducecardiovascularriskinwomenwithrecentpreeclampsia
AT tsigaseleni or214hearthealth4momsarandomizedtrialtoreducecardiovascularriskinwomenwithrecentpreeclampsia
AT fitzmauricegarrett or214hearthealth4momsarandomizedtrialtoreducecardiovascularriskinwomenwithrecentpreeclampsia
AT wilkinshauglouise or214hearthealth4momsarandomizedtrialtoreducecardiovascularriskinwomenwithrecentpreeclampsia
AT levkoffsue or214hearthealth4momsarandomizedtrialtoreducecardiovascularriskinwomenwithrecentpreeclampsia
AT richedwardsjanet or214hearthealth4momsarandomizedtrialtoreducecardiovascularriskinwomenwithrecentpreeclampsia